Article Details
Retrieved on: 2024-11-07 21:08:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
DK210 (EGFR) showed evidence of wild-type IL-2 signaling, CRS mitigation, and immune response signaling in patients with solid tumors.
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here